Paasa Logo
Korea United Pharm Inc. logo
033270KRXMarket closedOpens 9:00am KST

Korea United Pharm Inc.

₩17,860.00Last updated
-₩110.00 (0.61%)Past day
Timezone

Korea United Pharm Inc. (KRX: 033270) is trading at ₩17,860.00, about ₹1,289 at today's KRW/INR rate, as of 8 Oct 2026, 2:30 AM ET, down 0.61% today. Korea United Pharm is not currently available to trade on Paasa; this page shows its price, statistics and the Indian tax treatment for information.

Quote

Open:₩18,020.00
Previous close:₩17,970.00
Volume:11.17K

Today's low

₩17,720.00

Today's high

₩18,020.00

52 week low

₩16,100.00

52 week high

₩21,800.00

033270 opened at ₩18,020.00, closed previously at ₩17,970.00, and has traded between ₩16,100.00 and ₩21,800.00 over the past 52 weeks.

About

Korea United Pharm Inc. is a South Korean enterprise dedicated to the development, production, and distribution of a wide array of pharmaceutical products. The company's extensive portfolio encompasses therapeutic solutions for various medical fields, such as the respiratory, musculoskeletal, gastrointestinal, cardiovascular, and central nervous systems, in addition to treatments for cancer, infections, allergies, and immune disorders. It also supplies over-the-counter drugs. While deeply rooted in the South Korean market, the firm extends its reach internationally, exporting its medications to nearly 40 countries. Founded in 1987, Korea United Pharm Inc. is headquartered in Seoul, South Korea.

Country
KR
CEO
Duk-Young Kang
Exchange listed on
KRX
Industry
Drug Manufacturers - Specialty & Generic
Base currency
KRW
Full Time Employees
936
Sector
Healthcare
IPO date
11/02/2000

Key statistics

Avg. volume

31.42K

Market cap

₩257.93B

P/E Ratio

3.63

Price-to-sales ratio

0.87

Enterprise value

₩285.22B

Free cash flow yield

8.89%

Debt-to-equity ratio

0.03

Return on equity

8.43%

ROIC

7.94%

Beta

0.32

Dividend yield

3.42%

Last dividend

₩610.00

Financial overview

Revenue

₩288.76B

Earnings per share

₩2,614.37

Free cash flow

₩27.70B

Net profit margin

25.55%

Gross margin

59.02%

EBITDA

₩60.47B

Revenue growth

0.02%

Similar securities

This is not an investment recommendation

Korea United Pharm for Indian investors

Korea United Pharm is listed on the Korea Exchange. It is not currently available to trade on Paasa; the figures on this page are for information, and the tax notes below apply to Indian residents who hold it.

Taxes on Korea United Pharm for Indian residents

Trading and limits

Trading hours
9:00 am – 3:30 pm KST
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateDividends are taxed at your slab rate in India. Korea United Pharm’s current yield is 3.42%.Dividend tax explained

FAQs

Can I buy Korea United Pharm on Paasa?

Korea United Pharm (033270) has been listed on the Korea Exchange since 2000, in the Drug Manufacturers - Specialty & Generic industry. Korea United Pharm is not currently available to trade on Paasa; the figures on this page are for information. Indian residents who hold it through another broker still declare it under the rules below.

How much does one Korea United Pharm share cost in rupees?

One Korea United Pharm share is ₩17,860.00 — about ₹1,289 at a KRW/INR rate of 0.0722 on 8 Oct 2026. Both the Korea United Pharm price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for investing abroad from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability.

How are gains on Korea United Pharm shares taxed in India?

Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the KRW/INR rate on the purchase and the sale date, so the rupee move counts alongside the Korea United Pharm price.

Does Korea United Pharm pay a dividend, and how is it taxed in India?

Yes. Korea United Pharm pays a dividend and the current yield is 3.42%; the last declared dividend was ₩610.00 per share, about ₹44.03. Dividends are taxed at your slab rate in India.

When does KRX trade, in Indian time?

The Korea Exchange trades 5:30 am – 12:00 pm IST in Indian time.

Do I have to declare Korea United Pharm shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. The holding is reported with its cost and its closing value.

Does the rupee rate affect what I make on Korea United Pharm?

Yes. Korea United Pharm is priced in KRW, so your rupee outcome combines the KRW move with the KRW/INR move between the day you remit and the day you convert back.